Education
About Us
Working with TipRanks
Follow Us
Mayne Pharma Group Ltd. (AU:MYX)
:MYX
MYX Stock Chart & Stats
AU$6.01
-AU$0.13(-2.74%)
At close: 4:00 PM EST
AU$6.01
-AU$0.13(-2.74%)
Day’s Range― - ―
52-Week RangeAU$3.13 - AU$7.31
Previous CloseN/A
Volume149.18K
Average Volume (3M)593.75K
Market Cap
AU$264.05M
Enterprise ValueAU$344.73M
Total Cash (Recent Filing)AU$100.40M
Total Debt (Recent Filing)AU$41.27M
Price to Earnings (P/E)―
Beta0.68
Next Earnings
Feb 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.84
Shares Outstanding81,245,830
10 Day Avg. Volume776,050
30 Day Avg. Volume593,750
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)1.11
Price to Sales (P/S)1.01
P/FCF Ratio79.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Mayne Pharma Group News
MYX FAQ
What was Mayne Pharma Group Ltd.’s price range in the past 12 months?
Mayne Pharma Group Ltd. lowest share price was AU$3.13 and its highest was AU$7.31 in the past 12 months.
What is Mayne Pharma Group Ltd.’s market cap?
Mayne Pharma Group Ltd.’s market cap is AU$264.05M.
When is Mayne Pharma Group Ltd.’s upcoming earnings report date?
Mayne Pharma Group Ltd.’s upcoming earnings report date is Feb 19, 2026 which is in 64 days.
How were Mayne Pharma Group Ltd.’s earnings last quarter?
Mayne Pharma Group Ltd. released its earnings results on Aug 28, 2025. The company reported -AU$0.841 earnings per share for the quarter, missing the consensus estimate of AU$0.006 by -AU$0.847.
Is Mayne Pharma Group Ltd. overvalued?
According to Wall Street analysts Mayne Pharma Group Ltd.’s price is currently Overvalued.
Does Mayne Pharma Group Ltd. pay dividends?
Mayne Pharma Group Ltd. pays a Notavailable dividend of AU$0.544 which represents an annual dividend yield of N/A. See more information on Mayne Pharma Group Ltd. dividends here
What is Mayne Pharma Group Ltd.’s EPS estimate?
Mayne Pharma Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mayne Pharma Group Ltd. have?
Mayne Pharma Group Ltd. has 81,245,830 shares outstanding.
What happened to Mayne Pharma Group Ltd.’s price movement after its last earnings report?
Mayne Pharma Group Ltd. reported an EPS of -AU$0.841 in its last earnings report, missing expectations of AU$0.006. Following the earnings report the stock price went up 2.783%.
Which hedge fund is a major shareholder of Mayne Pharma Group Ltd.?
Currently, no hedge funds are holding shares in AU:MYX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Mayne Pharma Group Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:MYX Sentiment 70%
Sector Average 68%
Sector Average 68%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.78%
12-Months-Change
Fundamentals
Return on Equity
-21.13%
Trailing 12-Months
Asset Growth
-12.91%
Trailing 12-Months
Company Description
Mayne Pharma Group Ltd.
Mayne Pharma Group is a global specialty pharmaceutical company based in Australia, focused on developing and commercializing innovative products across various therapeutic areas, particularly in the fields of oncology, diabetes, and women's health. The company operates in both the prescription and over-the-counter markets, offering a range of pharmaceutical formulations and generic medicines. Mayne Pharma's portfolio includes a variety of specialty products and generic drugs, along with proprietary drug delivery systems that enhance the efficacy and safety of treatments.
MYX Company Deck
MYX Earnings Call
Q4 2025
0:00 / 0:00
Technical Analysis
Cogstate Ltd
―
Immutep Ltd
―
Dimerix Limited
―
Clarity Pharmaceuticals Ltd.
―
Cyclopharm Limited
―
Options Prices
Currently, No data available
---